[go: up one dir, main page]

DE69331459D1 - Parenterale immunisierung gegen rotavirus - Google Patents

Parenterale immunisierung gegen rotavirus

Info

Publication number
DE69331459D1
DE69331459D1 DE69331459T DE69331459T DE69331459D1 DE 69331459 D1 DE69331459 D1 DE 69331459D1 DE 69331459 T DE69331459 T DE 69331459T DE 69331459 T DE69331459 T DE 69331459T DE 69331459 D1 DE69331459 D1 DE 69331459D1
Authority
DE
Germany
Prior art keywords
rotavirus
immunization against
parenteral immunization
against rotavirus
vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69331459T
Other languages
English (en)
Other versions
DE69331459T2 (de
Inventor
K Estes
E Conner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baylor College of Medicine
Original Assignee
Baylor College of Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25430523&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69331459(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Baylor College of Medicine filed Critical Baylor College of Medicine
Application granted granted Critical
Publication of DE69331459D1 publication Critical patent/DE69331459D1/de
Publication of DE69331459T2 publication Critical patent/DE69331459T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/15Reoviridae, e.g. calf diarrhea virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/42Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum viral
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/04Inactivation or attenuation; Producing viral sub-units
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5252Virus inactivated (killed)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/54Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/54Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541Mucosal route
    • A61K2039/542Mucosal route oral/gastrointestinal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/545Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505Inorganic adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55566Emulsions, e.g. Freund's adjuvant, MF59
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011Details
    • C12N2720/12011Reoviridae
    • C12N2720/12311Rotavirus, e.g. rotavirus A
    • C12N2720/12322New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011Details
    • C12N2720/12011Reoviridae
    • C12N2720/12311Rotavirus, e.g. rotavirus A
    • C12N2720/12334Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Catalysts (AREA)
  • Medicinal Preparation (AREA)
DE69331459T 1992-07-10 1993-07-12 Parenterale immunisierung gegen rotavirus Expired - Fee Related DE69331459T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/911,593 US6780630B1 (en) 1992-07-10 1992-07-10 Parenteral immunization against rotavirus
PCT/US1993/006543 WO1994001134A1 (en) 1992-07-10 1993-07-12 Parenteral immunization against rotavirus

Publications (2)

Publication Number Publication Date
DE69331459D1 true DE69331459D1 (de) 2002-02-21
DE69331459T2 DE69331459T2 (de) 2002-06-20

Family

ID=25430523

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69331459T Expired - Fee Related DE69331459T2 (de) 1992-07-10 1993-07-12 Parenterale immunisierung gegen rotavirus

Country Status (14)

Country Link
US (1) US6780630B1 (de)
EP (1) EP0603386B1 (de)
JP (1) JPH07501558A (de)
KR (2) KR100354587B1 (de)
AT (1) ATE211923T1 (de)
AU (1) AU673370B2 (de)
CA (1) CA2116971A1 (de)
DE (1) DE69331459T2 (de)
DK (1) DK0603386T3 (de)
ES (1) ES2166763T3 (de)
IL (1) IL106306A (de)
NO (1) NO307815B1 (de)
PT (1) PT603386E (de)
WO (1) WO1994001134A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5626851A (en) * 1987-11-30 1997-05-06 The Wistar Institute Of Anatomy And Biology Rotavirus reassortant vaccine
US6210677B1 (en) * 1993-01-29 2001-04-03 Robert C. Bohannon Method to reduce the physiologic effects of drugs on mammals
US6673355B1 (en) 1995-06-14 2004-01-06 Baylor College Of Medicine Rotavirus enterotoxin NSP4 and methods of using same
AU6387196A (en) * 1995-06-14 1997-01-15 Baylor College Of Medicine Rotavirus enterotoxin nsp4 and methods of using same
US8357525B2 (en) 2007-09-04 2013-01-22 The United States of America, as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention Thermal inactivation of rotavirus
BRPI1007721B1 (pt) 2009-05-12 2020-04-28 The Government Of The Us Secretary Department Of Health And Human Services Centers For Disease Contr composição de vacina para uso na indução de uma resposta imunológica contra um rotavírus em um indivíduo, cepa de rotavírus isolado de cdc-9 e cepa de rotavírus isolado de cdc-66
SG11201610921PA (en) * 2014-07-18 2017-02-27 Msd Wellcome Trust Hilleman Lab Pvt Ltd A thermostable freeze dried rotavirus vaccine formulation and process to prepare thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2483779A1 (fr) * 1980-06-05 1981-12-11 Synthelabo Procede pour isoler des antigenes glycoproteiques viraux et son application a la preparation de vaccins
US4341763A (en) * 1981-03-10 1982-07-27 Smithkline-Rit Methods of vaccinating humans against rotavirus infection
US4636385A (en) * 1985-02-15 1987-01-13 The Wistar Institute Of Anatomy & Biology Vaccine, method for its preparation, and use thereof in vaccinating humans against rotavirus infection
US4861864A (en) * 1985-05-14 1989-08-29 Albert Einstein College of Medicine of Yeshiva University (a Div. of Yeshiva University) Rotavirus antigens
US4704275A (en) * 1985-08-26 1987-11-03 The United States Of America As Represented By The Department Of Health And Human Services Vaccine against rotavirus diseases
EP0251467A3 (de) * 1986-06-20 1988-07-20 Abbott Laboratories Zusammensetzungen und Verfahren zum Gebrauch eines Haupt-Aussen-Kapsid-Proteins (VP7) des Rotavirus SA-11
US4927628A (en) * 1987-09-21 1990-05-22 The United States Of America As Represented By The Department Of Health And Human Services Vaccine against rotavirus diseases and method of preparing same
US5147639A (en) * 1990-06-19 1992-09-15 Ambico, Inc. Type-c rotavirus cultures and uses therefor
CA2096315C (en) * 1990-11-16 1996-11-19 Richard L. Ward Human rotaviruses, vaccines and methods

Also Published As

Publication number Publication date
KR100354587B1 (ko) 2002-10-04
WO1994001134A1 (en) 1994-01-20
IL106306A (en) 2002-07-25
US6780630B1 (en) 2004-08-24
ES2166763T3 (es) 2002-05-01
EP0603386A1 (de) 1994-06-29
DK0603386T3 (da) 2002-03-11
EP0603386B1 (de) 2002-01-16
PT603386E (pt) 2002-06-28
AU673370B2 (en) 1996-11-07
KR940702388A (ko) 1994-08-20
DE69331459T2 (de) 2002-06-20
AU4674093A (en) 1994-01-31
ATE211923T1 (de) 2002-02-15
JPH07501558A (ja) 1995-02-16
CA2116971A1 (en) 1994-01-20
EP0603386A4 (en) 1996-05-29
IL106306A0 (en) 1993-11-15
NO940827D0 (no) 1994-03-09
NO940827L (no) 1994-05-09
NO307815B1 (no) 2000-06-05

Similar Documents

Publication Publication Date Title
PT714444E (pt) Atenuacao de um epitopo imunodominante de um antigenio para utilizacao em vacinas e imunoterapias para plantas, animais e homens
DE69333028D1 (de) Deletionsmutanten als impfstoffe gegen cholera
DE69637481D1 (de) Aus immunisierten Xenomäusen stammende menschliche Antikörper gegen IL-8
ATE295895T1 (de) Genetischer impfstoff gegen den immunschwäche virus
AU7814498A (en) Multivalent (in ovo) avian vaccine
HUP9701586A2 (hu) Javított inaktivált vakcinák
ATE211923T1 (de) Parenterale immunisierung gegen rotavirus
DK0536302T3 (da) Forbedrede adjuvanser og vacciner
TW340873B (en) Chicken anaemia agent vaccine
EP1395283A4 (de) Heterologer schutz, induziert durch immunisierung mit der invaplex-vakzine
ATE392429T1 (de) Lebend-impfstoff gegen heliobacter pylori
DK0563254T3 (da) Anvendelse af IL-4 til forstærkning af immunrespons på immunogener i vacciner
MX9301736A (es) Vacuna de bacterina-toxoide de pasteurella haemolytica tipo a-1.
PT1194450E (pt) Vacina inactivada contra a calicivirose felina
ES2055610T3 (es) Vacuna contra hrsv.
ES2102836T3 (es) El empleo de vacunas antihelminticas en el control de la enfermedad parasitaria asociada con la perdida de la inmunidad natural.
DE69123252D1 (de) Kreuzreaktive immunisierung gegen influenza
RU99110617A (ru) Способ сезонной вакцинопрофилактики полиомиелита на крайнем севере
FR2698271B1 (fr) Vaccin contre le virus de la leucémie bovine, nouveau peptide immunogène et kit de vaccination.
NO980721L (no) Vaksiner
RU2000112250A (ru) Способ сезонной вакцинопрофилактики паротита на крайнем севере
RU2004102296A (ru) Способ вакцинопрфилактики взрослых против дифтерии и столбняка на крайнем севере

Legal Events

Date Code Title Description
8363 Opposition against the patent
8339 Ceased/non-payment of the annual fee
8370 Indication related to discontinuation of the patent is to be deleted
8339 Ceased/non-payment of the annual fee